- Fed conditions → timing of meal zuzanna 2024-07-31 07:54
- ICH M13A Helmut 2024-07-31 09:14
- ICH M13A zuzanna 2024-07-31 10:32
- ICH M13A published Helmut 2024-07-31 12:21
- ICH M13A published zuzanna 2024-07-31 13:47
- ICH M13A published ElMaestro 2024-07-31 14:14
- ICH M13A published zuzanna 2024-08-01 12:49
- ICH M13A published qualityassurance 2024-08-02 05:09
- ICH M13A published ElMaestro 2024-08-02 15:14
- ICH M13A published zuzanna 2024-08-03 21:16
- ICH M13A published qualityassurance 2024-08-05 12:45
- ICH M13A published qualityassurance 2024-08-02 05:09
- ICH M13A published zuzanna 2024-08-01 12:49
- ICH M13A published ElMaestro 2024-07-31 14:14
- ICH M13A published zuzanna 2024-07-31 13:47
- ICH M13A published Helmut 2024-07-31 12:21
- ICH M13A zuzanna 2024-07-31 10:32
- ICH M13A Helmut 2024-07-31 09:14
- Consult animal trial design libaiyi 2024-07-03 11:52
- Consult trial design libaiyi 2024-07-03 09:12
- BE between one injection vs multiple injection products weiguo2122 2024-06-26 20:17
- BE between one injection vs multiple injection products weiguo2122 2024-06-27 15:07
- Therapeutic equivalence kishorpatil 2011-02-08 10:24
- Therapeutic equivalence? d_labes 2011-02-08 10:37
- Therapeutic equivalence? Dr_Dan 2011-02-08 14:40
- Therapeutic equivalence? d_labes 2011-02-08 14:45
- Therapeutic equivalence? bjkim97 2011-02-23 11:06
- Therapeutic equivalence? Dr_Dan 2011-02-28 14:53
- Therapeutic equivalence? bjkim97 2011-03-03 12:37
- Therapeutic equivalence? Dr_Dan 2011-02-28 14:53
- Therapeutic equivalence? Mauricio Sampaio 2024-06-17 02:21
- Therapeutic equivalence? Dr_Dan 2011-02-08 14:40
- Therapeutic equivalence raghu 2011-02-09 10:07
- Therapeutic equivalence? d_labes 2011-02-08 10:37
- Single dose PK study on Patients Pharma_88 2024-05-15 05:37
- Single dose PK study on Patients Ohlbe 2024-05-15 09:39
- Single dose PK study on Patients Pharma_88 2024-05-17 10:06
- No, sorry Ohlbe 2024-05-17 13:45
- No, sorry Pharma_88 2024-05-20 06:50
- Deviating from a guidance Helmut 2024-05-20 07:57
- Deviating from a guidance Pharma_88 2024-05-21 08:32
- No, sorry Ohlbe 2024-05-21 12:41
- Deviating from a guidance Helmut 2024-05-20 07:57
- No, sorry Pharma_88 2024-05-20 06:50
- No, sorry Ohlbe 2024-05-17 13:45
- Single dose PK study on Patients Pharma_88 2024-05-17 10:06
- Single dose PK study on Patients Ohlbe 2024-05-15 09:39
- Large sample size in a BE study Achievwin 2024-05-03 13:28
- My record: ≈400 Helmut 2024-05-03 13:34
- My record: ≈400 Achievwin 2024-05-03 13:49
- My record: ≈400 Helmut 2024-05-03 14:19
- My record: ≈400 nobody 2024-05-03 18:44
- n=180 4-period full replicate Helmut 2024-05-03 22:25
- n=180 4-period full replicate Achievwin 2024-05-06 15:56
- HVNTID! mittyri 2024-05-07 07:35
- n=180 4-period full replicate dshah 2024-05-08 16:11
- Lousy T/R-ratio Helmut 2024-05-08 16:18
- n=180 4-period full replicate Achievwin 2024-05-17 13:45
- n=180 4-period full replicate Achievwin 2024-05-06 15:56
- n=180 4-period full replicate Helmut 2024-05-03 22:25
- My record: ≈400 Achievwin 2024-05-03 13:49
- My record: ≈400 Helmut 2024-05-03 13:34
- Probability of Success in BE studies Achievwin 2024-05-03 13:43
- Probability of Success in BE studies Helmut 2024-05-03 14:15
- Probability of Success in BE studies Achievwin 2024-05-06 14:49
- Probability of Success in BE studies d_labes 2024-05-06 15:16
- Probability of Success in BE studies Achievwin 2024-05-06 15:31
- Assumptions (plural) Helmut 2024-05-06 15:31
- Assumptions (plural) Achievwin 2024-05-06 15:51
- Probability of Success in BE studies d_labes 2024-05-06 15:16
- Probability of Success in BE studies Achievwin 2024-05-06 14:49
- Probability of Success in BE studies Helmut 2024-05-03 14:15
- Ferrograd Folic 325 mg / 0.35 mg prolonged-release tablet Study Requirement / Analyte to measure JP2030 2024-04-29 07:18
- multiple dose studies Loky do 2024-03-04 10:27
- multiple dose studies dshah 2024-03-08 17:36
- multiple dose studies Loky do 2024-03-11 11:20
- multiple dose studies dshah 2024-03-12 17:37
- multiple dose studies Loky do 2024-03-11 11:20
- multiple dose studies dshah 2024-03-08 17:36
- crossover design when use RSABE with two test products Darborn 2023-08-22 02:24
- RSABE with two test products Helmut 2023-08-23 10:01
- RSABE with two test products Darborn 2023-08-23 11:13
- RSABE with two test products: Sample size? Helmut 2023-08-23 11:51
- RSABE with two test products: Sample size? Darborn 2023-08-30 08:07
- RSABE with two test products: Sample size? Helmut 2023-08-23 11:51
- RSABE with two test products fethiye 2024-02-23 07:14
- RSABE with two test products Darborn 2023-08-23 11:13
- crossover design when use ABEL with two test products BEQool 2024-02-22 09:15
- crossover design when use ABEL with two test products Helmut 2024-02-23 09:25
- crossover design when use ABEL with two test products BEQool 2024-02-25 09:59
- crossover design when use ABEL with two test products Helmut 2024-02-23 09:25
- RSABE with two test products Helmut 2023-08-23 10:01
- Steady state BE study dosing NK 2024-01-19 04:24
- Circadian rhythm? Helmut 2024-01-20 12:50
- Steady state BE study dosing dshah 2024-01-22 10:09
- AUC in steady state Helmut 2024-01-27 22:01
- AUC in steady state dshah 2024-01-27 22:06
- AUC in steady state Helmut 2024-01-27 22:16
- AUC in steady state dshah 2024-01-27 22:06
- AUC in steady state Helmut 2024-01-27 22:01
- Statistical Method and acceptance Vismayi 2024-01-23 09:29
- Mizolastine study design Bebac user 2023-12-20 18:47
- Single-dose study in patients Brus 2023-12-09 17:45
- Single-dose study in patients Helmut 2023-12-10 09:43
- Single-dose study in patients dshah 2023-12-11 10:44